Studies on specific targeting of IL-6 trans-signaling by using the sgp130Fc protein show a potentially novel strategy of renal fibrosis treatment by suppressing STAT3 activation without systemic IL-6 inhibition [8,27]. This evidence concerns the gene IL6 and renal fibrosis.